Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Naozhenning Granules
- Development stage
- Unknown
- Lead developer
- Zhendong Anxin Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Naozhenning Granules (脑震宁颗粒) is a Traditional Chinese Medicine (TCM) formulation developed and manufactured by Shanxi Zhendong Ante Biological Pharmaceutical Co., Ltd. (Zhendong Anxin). Administered orally as granules, it is primarily indicated for the treatment of brain concussion, cerebral post-traumatic syndrome, and brain trauma. The formulation is a complex mixture of bioactive constituents, including iridoids, butylphthalides, salvianolic acids, flavonoids, and jujubosides. According to TCM theory, Naozhenning Granules function to cool the blood, invigorate circulation, remove blood stasis, and soothe the nerves. Modern pharmacological research suggests that the drug acts through multiple signaling pathways, including the PI3K/Akt, MAPK, TGF-beta, and RAS pathways, to alleviate symptoms such as nausea and vomiting associated with cerebrovascular and traumatic brain conditions. It is currently approved and marketed in China.
- Brand names
- Naozhenning Granules
- Other names
- 脑震宁颗粒Naozhenning Keli
Beyond the preview
Go deeper on Naozhenning Granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Naozhenning Granules.